Chest
-
OSA PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: A cross-sectional review was performed in order to assess the ability of the neck circumference (NC) to predict the diagnosis of obstructive sleep apnoea syndrome (OSAS) in a population group from Timisoara, Romania. ⋯ The following authors have nothing to disclose: Stefan Mihaicuta, Izabella Anita Toth, Sorin ParalescuNo Product/Research Disclosure Information.
-
Cancer CasesSESSION TYPE: Case ReportsPRESENTED ON: Sunday, March 23, 2014 at 09:00 AM - 10:00 AMINTRODUCTION: Pseudomesotheliomatous adenocarcinoma(PMA) of the lung is an uncommon variant lung cancer that is clinically and radiographically difficult to distinguish from mesothelioma.[1] Based on previously reported cases, these patients tend to be older male smokers. Similar to mesothelioma, PMA of the lung has a poor overall survival of 6 months in the literature. ⋯ The following authors have nothing to disclose: Michael Braganza, Julie Chou, Juri Janovcik, Julie Jarand, Dina FisherNo Product/Research Disclosure Information.
-
Tuberculosis Case Report PostersSESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: In the Philippines, tuberculosis (TB, has been one of the most common causes of hemoptysis. This case report presents a patient with hemoptysis that may be a sequelae of chronic TB. However, further investigation reveals a concomitant non-tuberculous mycobacterial (NTM) infection and the co-existence of aspergilloma aggravating the condition. ⋯ The co-exsistence of NTM and Aspergilloma may complicate hemoptysis in a patient with an underlying chronic pulmonary insult. All efforts must be exhausted and diagnostic armaments be maximized in order to promptly address the needs of the patient.Reference #1: Non-tuberculous mycobacterial lung infection complicated by chronic necrotising pulmonary aspergillosis. I Hafeez,M F Muers, S A Murphy,E G V Evans, R C Barton, P McWhinney. Thorax 2000;55:717-719Reference #2: Coexistence of intracavitary fungal colonization (fungusball) and active tuberculosis. GISELA UNIS, PEDRO DORNELLES PICON(TE SBPT), LUIZ CARLOS SEVERO. J Bras Pneumol 2005; 31(2): 139-43.Reference #3: Emerging of Mycotic Infection in Patients Infected with Mycobacterium tuberculosis. Sunita Bansod and Mahendra Rai. World Journal of Medical Sciences 3 (2): 74-80, 2008DISCLOSURE: The following authors have nothing to disclose: John Noel Chan, Shirley Jane Panganiban, Angelo Adraneda, Jonathan Paolo RustiaNo Product/Research Disclosure Information.
-
Pulmonary Function TestingSESSION TYPE: Slide PresentationsPRESENTED ON: Sunday, March 23, 2014 at 04:15 PM - 05:15 PMPURPOSE: Exhaled nitric oxide (FeNO) and Methacholine challenge (MCH) are both utilized in the detection and management of numerous pulmonary diseases. MCH is a measure of direct airway hyperresponsiveness. FeNO measures bronchial epithelial damage from eosinophilic bronchitis whether asthma or non-asthma related. FeNO has an attractive performance profile, as it is a cheaper and less invasive test. We hypothesize that FeNO can decrease the need for MCH testing. ⋯ The following authors have nothing to disclose: Andrew Nickels, Kenneth Parker, Paul Scanlon, Kaiser LimNo Product/Research Disclosure Information.
-
COPD Epidemiology & Physiology PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: COPD exacerbations are important and affects the course of the disease. Clinical trials showed that a subgroup of COPD patients had more exacerbations independent from their FEV1 values and thus a frequent exacerbation subgroup was defined. Small-airway damage has a role for the disease progression of COPD, but the exact relationship between small-airway damage and COPD exacerbations is not entirely clarified. In our study, we investigated the COPD patients who had frequent exacerbations in terms of small airway damage and their difference from patients who had not frequent exacerbations. ⋯ The following authors have nothing to disclose: Yelda Varol, Ceyda Anar, Levent Usta, Gunseli Balci, Rifat OzcacarNo Product/Research Disclosure Information.